Assignee
SHANGHAI HANSOH BIOMEDICAL CO LTD
CN·8 granted patents·29 pending applications·3 citations·filing 2015–2025
Top patents by PatentIndex Score
37 records- 0181US12466823B2Inhibitor containing bicyclic derivative, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Granted Nov 11, 2025·1 cites·18 claims
- 0277US2026042759A1Inhibitor containing bicyclic derivative, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2025·Application pending·0 cites
- 0372US2026085045A1Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2025·Application pending·0 cites
- 0467US10428081B2EGFR inhibitor, preparation method and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2018·Granted Oct 1, 2019·1 cites·20 claims
- 0563US10259820B2EGFR inhibitor, preparation method and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2015·Granted Apr 16, 2019·1 cites·28 claims
- 0663US2025367311A1Pharmaceutical composition containing an antibody-drug conjugate and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 0762US12540190B2Anti-BCMA antibody, antigen-binding fragment thereof and medical use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Granted Feb 3, 2026·0 cites·20 claims
- 0862US2024390509A1Antibody-drug conjugate, preparation method therefor, and pharmaceutical use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 0960US12497366B2Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2025·Granted Dec 16, 2025·0 cites·15 claims
- 1059US2024376108A1Salt and crystal form of pyrazole-containing polycyclic derivative, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 1158US2025152564A1Propylene ketone-containing bioinhibitor, preparation method therefor, and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 1257US2025059196A1Tricyclic derivative inhibitor, preparation method therefor, and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 1356US2025368616A1Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 1456US2024165252A1Antibody-drug conjugate and medical use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 1556US2024368123A1Aromatic ring-containing biological antagonist, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 1656US2025206718A1Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 1755US2023406865A1Crystal form of free base of inhibitor containing bicyclic ring derivative and preparation method and application of crystal formSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2021·Application pending·0 cites
- 1855US2023374149A1Anti-trop-2 antibody, antigen-binding fragment thereof or mutant thereof, and medical use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2021·Application pending·0 cites
- 1955US2024360109A1Cycloalkene derivative regulator, preparation method therefor, and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 2055US2025066360A1Pyridine-containing polycyclic derivative, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 2154US2024208981A1Nitrogen-containing heterocyclic polycyclic compound, preparation method therefor, and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 2254US2025388578A1Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2025·Application pending·0 cites
- 2353US2024228490A1Heterocyclic derivative inhibitor and preparation method therefor and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 2452US2025051316A12-(aryl-2-yl) morpholine and deuterated derivative thereof, preparation method therefor and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 2551US12459931B2Benzothiophene derivative regulator, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Granted Nov 4, 2025·0 cites·16 claims
- 2651US2023134869A1Crystal form of free alkali of nitrogen-containing aromatic derivativesSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2021·Application pending·0 cites
- 2751US2023271969A1Nitrogen-containing fused ring derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2021·Application pending·0 cites
- 2850US2023105212A1Biphenyl derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 2950US2024325394A1Salt and crystal form of nitrogen-containing heterocyclic derivative, preparation method therefor and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2021·Application pending·0 cites
- 3050US2023014383A1Three fused ring derivative-containing salt or crystal form and pharmaceutical composition thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 3150US2023118497A1Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 3248US2025313564A1Acidic salt or crystal form of nitrogen-containing fused ring derivative inhibitor, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 3347US2024254109A1Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 3443US12497396B2Nitrogen-containing heterocyclic derivatives, method therefor and application therefor as inhibitors of KRAS G12C for the treatment of cancersSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Granted Dec 16, 2025·0 cites·16 claims
- 3542US2023072897A1Anti-b7-h4 antibody-drug conjugate and medicinal use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 3642US2023076435A1Modifier of four-membered ring derivative, preparation method and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 3737US12590118B2Salt and crystal form of steroid derivative regulatorSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Granted Mar 31, 2026·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI HANSOH BIOMEDICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →